Boston Scientific Corp (Boston Scientific) develops, manufactures, and commercializes medical devices used in interventional medical procedures. The company serves industries related to cardiovascular, respiratory, digestive, oncological, neurological, and urological diseases and conditions. Its product portfolio finds application in various medical procedures such as interventional cardiology, cardiac rhythm management, peripheral interventions, electrophysiology, endoscopy, urology and pelvic health, and neuromodulation.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Boston Scientifics research and development initiatives are focused on developing next-generation and novel technology offerings across multiple programs and divisions. The company focuses on the development of less invasive procedures in cardiovascular, rhythm management, and medical surgical areas. It invests in the development of new and advanced technologies, and the enhancement of existing ones. The company also works with several leading research institutions, universities and clinicians worldwide to develop, evaluate and clinically test its products. The company is developing digital tools and technologies to enhance competitiveness, deliver remote physician education, drive patient engagement, and increase sales force productivity. Boston Scientific collaborates with leading research institutions, universities, and clinicians globally to develop, evaluate, and clinically test products, and is expanding collaborations to include R&D teams in emerging market countries. The company’s major R&D platforms include drug-eluting stent platforms, differentiated drug-eluting technologies, FFR integrated imaging platform, TAVR platform, left atrial appendage closure platform, mapping and navigation platform, drug-coated balloons, and deep brain stimulation (DBS) platform, among others. In FY2025, the company spent US$2,052 million on its R&D activities, which as a percentage of revenue stood at 10.2%, and grew 27.1% YoY.